Soaring Demand Set to Propel Edible Vaccine Market to $13.35 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Edible Vaccine Market Through 2025?
The edible vaccine market has seen robust growth in recent years. It is projected to grow from $8.77 billion in 2024 to $9.51 billion in 2025 at a CAGR of 8.4%. Drivers of historic growth include genetic engineering advancements, limitations of conventional vaccines, biopharming progress, focus on global immunization, and government support and funding.

What's the Projected Size of the Global Edible Vaccine Market by 2029?
The market for edible vaccines is predicted to experience significant expansion in the coming years, growing to a valuation of $13.35 billion by 2029, with a compound annual growth rate of 8.8%. Several factors contribute to this projected growth during the forecast period, including increased demand due to pandemic readiness, progress in plant-based biotechnologies, rising public understanding and acceptance of genetically engineered food products, solving issues related to the cold chain, and alignment with food safety initiatives. Other forward-looking trends include extending into the animal health sector, increased engagement with biopharming, personalized diets and immunizations, eco-friendly and sustainable vaccines, and the creation of multi-antigen edible vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

Top Growth Drivers in the Edible Vaccine Industry: What's Accelerating the Market?
The edible vaccine market is predicted to see significant growth due to the rising occurrence of infectious diseases. These illnesses, triggered by damaging microorganisms such as bacteria, viruses, fungi, or parasites attacking and proliferating within the body, are becoming increasingly common. This rise in prevalence can be attributed to factors like globalization, climate change, urbanization, and antibiotic resistance, which aid in the spread and introduction of new pathogens. Edible vaccines, which boost immune responses by encouraging the consumption of genetically modified food producing antigens, offer an affordable and non-invasive approach to immunization. For example, the Centers for Disease Control and Prevention (CDC), a public health agency based in the United States, reported that the number of tuberculosis cases had surged from 8,320 in 2022 to 9,615 in 2023. This marked a rise of 1,295 cases, with the rate per 100,000 people increasing from 2.5 in 2022 to 2.9 in 2023. Hence, these mounting instances of infectious diseases are acting as a catalyst for the expansion of the edible vaccine market.

Get your free sample here:
#Claim Your Free Sample Report:#
https://www.thebusinessresearchcompany.com/sample_request?id=16215&type=smp

What Trends Will Shape the Edible Vaccine Market Through 2029 and Beyond?
Prominent businesses in the edible vaccine market are channeling their efforts towards creating novel solutions like oral cholera vaccine (OCV) to tackle the worldwide cholera predicament. OCV is a vaccine taken orally designed to mitigate cholera, a serious diarrheal ailment provoked by Vibrio cholerae bacteria. For example, Bharat Biotech International Limited, a leading Indian biotech enterprise, rolled out Hillchol, an oral cholera vaccine (OCV), comprised of multiple distinctive attributes, in August 2024. This live-attenuated vaccine triggers both systemic and mucosal immune responses, providing defense against cholera. What sets Hillchol apart is its simple application method and its lack of requirement for cold storage, making it suitable for areas with limited resources. Additionally, a single dose provides prolonged immunity.

What Are the Main Segments in the Edible Vaccine Market?
The edible vaccine market covered in this report is segmented -

1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals

Subsegments:
1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Synthetic DNA Vaccines
4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines, Live Attenuated Bacterial Vaccines
5) By Other Types: Virus-Like Particle (VLP) Vaccines, mRNA Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19040&type=smp

Which Top Companies are Driving Growth in the Edible Vaccine Market?
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

Which Regions Will Dominate the Edible Vaccine Market Through 2029?
North America was the largest region in the edible vaccine market in 2024. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19040

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.